H.R. 3008 · 118th Congress (2023–2025)
Drug Shortage Prevention Act of 2023
This bill requires drug manufacturers to notify the Food and Drug Administration (FDA) if there is an increased demand for certain critical essential medicines that may result in a shortage.
Currently, drug manufacturers are required to notify the FDA in the event of a discontinuation or interruption in the supply of prescription drugs that are life-supporting, life-sustaining, or used for a debilitating disease or condition, including those used in medical emergencies, surgeries, or public health emergencies.
The bill requires drug manufacturers to also notify the FDA if there is an increased demand for such drugs that lasts for at least six weeks and that may result in a shortage. Manufacturers must initially notify the FDA of the increased demand within 48 hours after this six-week period and must submit an additional notice within 30 days of the initial notification. The notice must include the reasons for the increased demand, the expected duration, and any other information the FDA requires. The bill's requirements apply to both prescription and nonprescription drugs.
Show official title
To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical essential medicines of increased demand of such drugs, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 3008’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Sara Jacobs (D-CA-51)
- Cosponsors
49 cosponsors
29 original · 20 later
2 R · 47 D
- Rep. Colin Z. Allred (D-TX-32)· Original · Apr 28, 2023
- Rep. Lisa Blunt Rochester (D-DE)· Original · Apr 28, 2023
- Rep. Emanuel Cleaver (D-MO-5)· Original · Apr 28, 2023
- Rep. Yvette D. Clarke (D-NY-9)· Original · Apr 28, 2023
- Rep. Steve Cohen (D-TN-9)· Original · Apr 28, 2023
- Rep. Troy A. Carter (D-LA-2)· Original · Apr 28, 2023
- Rep. Jasmine Crockett (D-TX-30)· Original · Apr 28, 2023
- Rep. Yadira Caraveo (D-CO-8)· Original · Apr 28, 2023
- Rep. Lloyd Doggett (D-TX-37)· Original · Apr 28, 2023
- Rep. Raúl M. Grijalva (D-AZ-7)· Original · Apr 28, 2023
- Rep. Jesús G. "Chuy" García (D-IL-4)· Original · Apr 28, 2023
- Rep. Jared Huffman (D-CA-2)· Original · Apr 28, 2023
- Rep. Sheila Jackson Lee (D-TX-18)· Original · Apr 28, 2023
- Rep. Ann M. Kuster (D-NH-2)· Original · Apr 28, 2023
- Rep. Ro Khanna (D-CA-17)· Original · Apr 28, 2023
- Rep. Andy Kim (D-NJ-3)· Original · Apr 28, 2023
- Rep. Barbara Lee (D-CA-12)· Original · Apr 28, 2023
- Rep. John B. Larson (D-CT-1)· Original · Apr 28, 2023
- Rep. James P. McGovern (D-MA-2)· Original · Apr 28, 2023
- Rep. Cory Mills (R-FL-7)· Original · Apr 28, 2023
- Del. Eleanor Holmes Norton (D-DC)· Original · Apr 28, 2023
- Rep. Alexandria Ocasio-Cortez (D-NY-14)· Original · Apr 28, 2023
- Rep. Ayanna Pressley (D-MA-7)· Original · Apr 28, 2023
- Rep. Adam Smith (D-WA-9)· Original · Apr 28, 2023
- Rep. Adam B. Schiff (D-CA-28)· Original · Apr 28, 2023
- Rep. Jill N. Tokuda (D-HI-2)· Original · Apr 28, 2023
- Rep. Nydia M. Velázquez (D-NY-7)· Original · Apr 28, 2023
- Rep. Marc A. Veasey (D-TX-33)· Original · Apr 28, 2023
- Rep. Bonnie Watson Coleman (D-NJ-12)· Original · Apr 28, 2023
- Rep. Kathy Castor (D-FL-14)· Later · Jun 5, 2023
- Rep. Angie Craig (D-MN-2)· Later · Jun 6, 2023
- Rep. Elissa Slotkin (D-MI-7)· Later · Jun 12, 2023
- Rep. Stephanie I. Bice (R-OK-5)· Later · Jun 14, 2023
- Rep. John P. Sarbanes (D-MD-3)· Later · Jun 15, 2023
- Rep. Madeleine Dean (D-PA-4)· Later · Jun 20, 2023
- Rep. Patrick Ryan (D-NY-18)· Later · Jun 21, 2023
- Rep. Christopher R. Deluzio (D-PA-17)· Later · Jul 11, 2023
- Rep. Sharice Davids (D-KS-3)· Later · Jul 11, 2023
- Rep. Lizzie Fletcher (D-TX-7)· Later · Jul 11, 2023
- Rep. Tony Cárdenas (D-CA-29)· Later · Jul 17, 2023
- Rep. Scott H. Peters (D-CA-50)· Later · Jul 20, 2023
- Rep. Val T. Hoyle (D-OR-4)· Later · Jul 26, 2023
- Rep. Maxwell Frost (D-FL-10)· Later · Aug 29, 2023
- Rep. Teresa Leger Fernandez (D-NM-3)· Later · Nov 14, 2023
- Rep. Stephen F. Lynch (D-MA-8)· Later · Dec 5, 2023
- Rep. Mike Quigley (D-IL-5)· Later · Jun 4, 2024
- Rep. Chris Pappas (D-NH-1)· Later · Jul 5, 2024
- Rep. Rashida Tlaib (D-MI-12)· Later · Jul 10, 2024
- Rep. Paul Tonko (D-NY-20)· Later · Jul 18, 2024
- Policy area
- Health
- Subjects
- Emergency medical services and trauma care
- Government information and archives
- Manufacturing
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Apr 28, 2023 – May 5, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Sep 14, 2023 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Drug Shortage Prevention Act of 2023
Display title, Short title · Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical essential medicines of increased demand of such drugs, and for other purposes.
Official title · Introduced in House